Engineering cytokine immunotherapies via cell surface targeting
Cancer immunotherapy targets immune cells to trigger a highly specific, long-lasting anti-tumor response. With the clinical success of immune checkpoint blockade and the development of promising next-generation agents, immunotherapy is steadily growing as a key pillar of the oncology clinic alongsid...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Published: |
Massachusetts Institute of Technology
2024
|
| Online Access: | https://hdl.handle.net/1721.1/155380 |